Showing results (261-270 of 861) with videos related to
Sort By:
Pageof 87
Med (New York, N.Y.)|April 19, 2021
Mucosal-associated invariant T cell responses differ by sex in COVID-19Chen Yu, Sejiro Littleton, Nicholas S Giroux, et al.Med (New York, N.Y.)|August 25, 2020
Validation of Predictors of Disease Severity and Outcomes in COVID-19 Patients: A Descriptive and Retrospective StudyLi Tan, Xia Kang, Xinran Ji, et al.Med (New York, N.Y.)|August 25, 2020
Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral InfectionsBrianna J Stubbs, Andrew P Koutnik, Emily L Goldberg, et al.Med (New York, N.Y.)|August 25, 2020
Virus-Host Interactome and Proteomic Survey Reveal Potential Virulence Factors Influencing SARS-CoV-2 PathogenesisJingjiao Li, Mingquan Guo, Xiaoxu Tian, et al.Med (New York, N.Y.)|April 27, 2023
RNase2 is a possible trigger of acute-on-chronic inflammation leading to mRNA vaccine-associated cardiac complicationEugenia Z Ong, Clara W T Koh, Danny J H Tng, et al.Med (New York, N.Y.)|May 26, 2023
Impact of extended interval dosing of ocrelizumab on immunoglobulin levels in multiple sclerosisAaron Schuckmann, Falk Steffen, Frauke Zipp, et al.Med (New York, N.Y.)|August 13, 2022
The challenge of BWAs: Unknown unknowns in feature space and variancePeter A Bandettini, Javier Gonzalez-Castillo, Dan Handwerker, et al.Med (New York, N.Y.)|November 12, 2022
Fields to fermentors: Brewing botanical chemotherapeutic precursors using genetically engineered yeastPrashanth Srinivasan, Christina D SmolkeMed (New York, N.Y.)|August 23, 2022
Safety and immunogenicity of anti-SARS-CoV-2 heterologous scheme with SOBERANA 02 and SOBERANA Plus vaccines: Phase IIb clinical trial in adultsMaría Eugenia Toledo-Romani, Mayra García-Carmenate, Leslyhana Verdecia-Sánchez, et al.Med (New York, N.Y.)|March 2, 2023
Evolution of long-term vaccine-induced and hybrid immunity in healthcare workers after different COVID-19 vaccine regimensShona C Moore, Barbara Kronsteiner, Stephanie Longet, et al.Pageof 87